IHS Chemical Week

People & Business :: Responsible Care

U.S. Regulations Take Shape for Follow-On Biologics

1:34 PM MDT | August 6, 2007 | Alex Scott

Bipartisan members of Congress were working toward an agreement on new regulations at CW’s press time last week that could enable the swift approval in the U.S. of generic biologic drugs, otherwise known as biogenerics or follow-on biologics. The regulations could open the door to a wave of lower-cost biotech drugs. Prospects for a new bill to facilitate the introduction of biogenerics have improved since the Democrats took control of Congress, industry representatives say. The U.S. FDA says it would welcome a new biogenerics bill. Janet Woodcock...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa